Clinical Trial Update: Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial examined the short-term clinical effects of tolvaptan in patients hospitalized for worsening heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Cardiovascular Clinical Sciences Inc | Conditions: Heart Failure | Phase 3 | Status: COMPLETED